ALFA Filings
Every announcement, straight from the exchange
Every Astec Lifesciences financial results announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Astec Lifesciences Ltd reported revenue from operations of ₹72 Cr (-2.3% YoY) and a net loss of ₹37.4 Cr for Q2 FY27.
Astec Lifesciences Ltd reported revenue from operations of ₹83.6 Cr (-8.2% YoY) and a net loss of ₹18.7 Cr for Q1 FY27.
Astec Lifesciences Ltd reported revenue from operations of ₹158.6 Cr (+32.7% YoY) and a net loss of ₹7.5 Cr for Q4 FY26.
Astec LifeSciences Limited reported its audited financial results for the quarter and year ended March 31, 2026. The Board also approved the appointment of new directors including Mr. Vishal Sharma and Mr. Burjis Godrej as Non-Executive Directors, and fixed July 31, 2026, as the date for its 32nd Annual General Meeting.
Astec Lifesciences Ltd reported a net loss of ₹15.7 Cr for Q3 FY26.